Inventor · disambiguated record
Omid Vafa
Also filed as: VAFA OMID
39 granted patents·34 pending applications·2,589 citations·filing 2003–2023
99Inventor score
Top patents by PatentIndex Score
73 records- 0199US8039592B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2007·Granted Oct 18, 2011·86 cites·19 claims
- 0299US7662925B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2006·Granted Feb 16, 2010·349 cites·15 claims
- 0399US7317091B2Optimized Fc variantsXENCOR INC·Filed 2004·Granted Jan 8, 2008·872 cites·1 claims
- 0498US10584176B2Fc variants with increased affinity for FcγRIIcXENCOR INC·Filed 2018·Granted Mar 10, 2020·21 cites·10 claims
- 0598US9051373B2Optimized Fc variantsXENCOR INC·Filed 2013·Granted Jun 9, 2015·40 cites·4 claims
- 0698US8937158B2Fc variants with increased affinity for FcγRIIcLAZAR GREGORY ALAN·Filed 2007·Granted Jan 20, 2015·56 cites·8 claims
- 0798US8735545B2Fc variants having increased affinity for fcyrllcLAZAR GREGORY ALAN·Filed 2007·Granted May 27, 2014·59 cites·9 claims
- 0898US8388955B2Fc variantsLAZAR GREGORY ALAN·Filed 2007·Granted Mar 5, 2013·104 cites·4 claims
- 0998US8383109B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2012·Granted Feb 26, 2013·40 cites·4 claims
- 1098US8188231B2Optimized FC variantsLAZAR GREGORY ALAN·Filed 2005·Granted May 29, 2012·188 cites·10 claims
- 1198US8124731B2Optimized Fc variants and methods for their generationLAZAR GREGORY ALAN·Filed 2007·Granted Feb 28, 2012·55 cites·4 claims
- 1298US8101720B2Immunoglobulin insertions, deletions and substitutionsLAZAR GREGORY A·Filed 2008·Granted Jan 24, 2012·174 cites·8 claims
- 1398US8093359B2Optimized Fc variants and methods for their generationLAZAR GREGORY ALAN·Filed 2007·Granted Jan 10, 2012·58 cites·19 claims
- 1498US8084582B2Optimized anti-CD20 monoclonal antibodies having Fc variantsDAHIYAT BASSIL I·Filed 2005·Granted Dec 27, 2011·115 cites·8 claims
- 1597US10184000B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2016·Granted Jan 22, 2019·20 cites·38 claims
- 1697US8753629B2Optimized Fc variantsLAZAR GREGORY ALAN·Filed 2013·Granted Jun 17, 2014·29 cites·26 claims
- 1797US8093357B2Optimized Fc variants and methods for their generationLAZAR GREGORY ALAN·Filed 2006·Granted Jan 10, 2012·51 cites·3 claims
- 1896US10053513B2Antibody Fc mutants with ablated effector functionsJANSSEN BIOTECH INC·Filed 2015·Granted Aug 21, 2018·15 cites·5 claims
- 1996US9637549B2Antibody Fc mutants with ablated effector functionsJANSSEN BIOTECH INC·Filed 2015·Granted May 2, 2017·8 cites·1 claims
- 2096US9353187B2Optimized FC variants and methods for their generationXENCOR INC·Filed 2013·Granted May 31, 2016·21 cites·9 claims
- 2196US8961967B2Antibody Fc mutants with ablated effector functionsSTROHL WILLIAM·Filed 2010·Granted Feb 24, 2015·56 cites·10 claims
- 2296US8858937B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2013·Granted Oct 14, 2014·20 cites·9 claims
- 2396US8802823B2Optimized Fc variantsXENCOR INC·Filed 2013·Granted Aug 12, 2014·24 cites·18 claims
- 2495US10183999B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2016·Granted Jan 22, 2019·10 cites·19 claims
- 2595US8734791B2Optimized fc variants and methods for their generationLAZAR GREGORY ALAN·Filed 2012·Granted May 27, 2014·19 cites·11 claims
- 2694US11186639B2Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOONE INC·Filed 2021·Granted Nov 30, 2021·7 cites·20 claims
- 2794US9657106B2Optimized Fc variantsXENCOR INC·Filed 2014·Granted May 23, 2017·13 cites·16 claims
- 2893US11390681B2Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOTWO INC·Filed 2021·Granted Jul 19, 2022·8 cites·20 claims
- 2993US8399618B2Immunoglobulin insertions, deletions, and substitutionsLAZAR GREGORY ALAN·Filed 2011·Granted Mar 19, 2013·24 cites·9 claims
- 3091US10894836B2Antibody Fc mutants with ablated effector functionsJANSSEN BIOTECH INC·Filed 2018·Granted Jan 19, 2021·7 cites·5 claims
- 3191US10113001B2Fc variants with increased affinity for FcyRIIcXENCOR INC·Filed 2014·Granted Oct 30, 2018·7 cites·30 claims
- 3290US9663582B2Optimized Fc variantsXENCOR INC·Filed 2014·Granted May 30, 2017·6 cites·30 claims
- 3388US8753628B2Optimized Fc variantsLAZAR GREGORY ALAN·Filed 2013·Granted Jun 17, 2014·5 cites·14 claims
- 3488US8735547B2Optimized Fc VariantsXENCOR INC·Filed 2013·Granted May 27, 2014·5 cites·8 claims
- 3587US9193798B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2014·Granted Nov 24, 2015·4 cites·8 claims
- 3687US8883147B2Immunoglobulins insertions, deletions, and substitutionsLAZAR GREGORY·Filed 2013·Granted Nov 11, 2014·11 cites·11 claims
- 3783US2025066476A1Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOONE INC·Filed 2023·Application pending·0 cites
- 3880US2024026023A1OPTIMIZED Fc VARIANTSXENCOR INC·Filed 2023·Application pending·0 cites
- 3977US8809503B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2013·Granted Aug 19, 2014·1 cites·11 claims
- 4076US9714282B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2014·Granted Jul 25, 2017·1 cites·8 claims
- 4174US2022332820A1Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOONE INC·Filed 2021·Application pending·0 cites
- 4273US11820830B2Optimized Fc variantsXENCOR INC·Filed 2020·Granted Nov 21, 2023·0 cites·23 claims
- 4372US2023203161A1Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOBIO INC·Filed 2021·Application pending·0 cites
- 4469US2015030592A1OPTIMIZED Fc VARIANTSXENCOR INC·Filed 2014·Application pending·0 cites
- 4569US2018208668A1OPTIMIZED Fc VARIANTSXENCOR INC·Filed 2017·Application pending·0 cites
- 4667US2007237767A1Fc Variants Having Decreased Affinity for FcyRlllaXENCOR INC·Filed 2007·Application pending·0 cites
- 4767US2007286859A1Fc Variants Having Decreased Affinity for FcyRlXENCOR INC·Filed 2007·Application pending·0 cites
- 4867US2021155711A1Antibody Fc Mutants with Ablated Effector FunctionsJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 4967US2007248603A1Fc Variants with Increased Affinity for FcyRllaXENCOR INC·Filed 2007·Application pending·0 cites
- 5067US2007243188A1Fc Variants Having Decreased Affinity for FcyRllaXENCOR INC·Filed 2007·Application pending·0 cites
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Omid Vafa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →